News Articles Tagged: ABCG2

YHO-13177 and Drug Resistance: A Focus on BCRP/ABCG2 Mechanisms

Examine the intricate relationship between YHO-13177, BCRP/ABCG2, and drug resistance, offering insights into how this inhibitor aids in overcoming therapeutic challenges.

The Role of Telatinib in Overcoming Cancer Drug Resistance

Investigate how Telatinib (CAS 332012-40-5) addresses multidrug resistance in cancer, enhancing the efficacy of chemotherapy through its unique inhibitory mechanisms.